;

Abstrak


PERBANDINGAN TERJADINYA TRANSLOKASI KUMAN SEBAGAI PARAMETER TRANSLOKASI VIRUS COVID-19 ANTARA ALAT PELINDUNG DIRI LEVEL III DIBANDINGKAN DENGAN SUNS (SURGEONS OF UNS) PADA TENAGA MEDIS YANG BERTUGAS DI RUANG ISOLASI COVID-19 RSUD DR MOEWARDI SURAKARTA


Oleh :
Taufik Hidayanto - S561802009 - Fak. Kedokteran

Abstract: Background: Nipple-sparing mastectomies (NSMs) are a relatively new
method of conservatism in the treatment of breast cancer. Most of the breast skin is left
intact during NSM, creating a pocket that can be filled with an implant or an
autologous graft for a rapid reconstruction that yields an excellent cosmetic outcome.
Combining prosthetic-based breast restoration with autologous flaps, such the
latissimus dorsi (LD) flap, may be necessary to achieve symmetry. Case Description :
A 45 year old woman who developed a breast deformity following a mastectomy for
breast cancer. The Latissimus dorsi (LD) flap was chosen because it is a thin layer flap
with good vascularization. The Latissimus dorsi (LD) flap, on the other hand,
necessitates a different skin incision than the mastectomy. An inframammary
adipofascial flap has been used as an autologous flap in conjunction with prostheticbased
breast reconstruction subsequent to nipple-sparing mastectomy (NSM). In this
instance, the Latissimus dorsi muscle flap was employed in the axillary and breast
regions. The Latissimus dorsi (LD) flap was deemed suitable as it can provide
extensive coverage without any delay in the transfer procedure. Anatomically, this flap
and its vascular supply are quite consistent. The arterial supply is provided by the
thoraco-dorsal artery which provides a large branch to the serratus anterior muscle and
provides a cutaneous branch. Successful management of the infection, postoperative
partial weight bearing, and restricted range of motion in the affected breast was
anticipated. Conclusion: The latissimus dorsi flap is a safe choice for skin regeneration
after a nipple sparing mastectomy. This procedure has the advantage of minimizing
donor site morbidity.